EnVVeno Medical Corporation (NASDAQ:NVNO) | Finanzwire

Basculer en Français

9475	Companies
185442	Keywords
117783	Articles
99298	Press releases

Headlines Articles Press releases EnVVeno Medical Corporation

Home
Companies
EnVVeno Medical Corporation

BRIEF

published on 08/01/2024 at 14:10, 1 year 4 months ago

EnVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Financial Results FDA Approval Corporate Update Venous Disease VenoValve Trial
PRESS RELEASE

published on 08/01/2024 at 14:05, 1 year 4 months ago

enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reported financial results and clinical program updates for Q2 2024, including positive VenoValve trial data and progress on enVVe valve launch. Cash balance of $39.1M to fund operations till 2025

Financial Results Cash Balance VenoValve EnVVeno Medical Corporation EnVVe Valve Launch
BRIEF

published on 06/25/2024 at 15:05, 1 year 5 months ago

EnVVeno Medical to Participate in the Virtual Investor Closing Bell Series

EnVVeno Medical VenoValve SAVVE Trial Venous Disease Virtual Investor Closing Bell Series
PRESS RELEASE

published on 06/25/2024 at 15:00, 1 year 5 months ago

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Robert Berman, CEO of enVVeno Medical, to discuss positive venous ulcer healing data in upcoming live webcast. Learn about the VenoValve technology and company advancements

EnVVeno Medical VenoValve SAVVE Trial Robert Berman Venous Disease
BRIEF

published on 06/21/2024 at 14:40, 1 year 5 months ago

Positive Interim Results for enVVeno Medical’s VenoValve in SAVVE Trial

FDA Approval VenoValve SAVVE Trial Venous Ulcers
PRESS RELEASE

published on 06/21/2024 at 14:35, 1 year 5 months ago

Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting
Veno Medical Corporation presents positive interim data on VenoValve for venous ulcer healing at Society for Vascular Surgery meeting. Company aims for FDA approval in Q4 2024

FDA Approval VenoValve Venous Ulcers Veno Medical Corporation SAVVE U.S. Pivotal Trial
BRIEF

published on 06/17/2024 at 18:05, 1 year 5 months ago

New Interim Venous Ulcer Healing Data from enVVeno Medical VenoValve Trial to be Presented at VAM2024

EnVVeno Medical VenoValve SAVVE Trial Venous Ulcer VAM2024
PRESS RELEASE

published on 06/17/2024 at 18:00, 1 year 5 months ago

New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical Corporation to present new interim venous ulcer healing data from VenoValve U.S. trial at VAM2024. Study focuses on treatment of venous disease with innovative bioprosthetic solutions

VenoValve EnVVeno Medical Corporation Venous Disease SAVVE Study Vascular Annual Meeting 2024
BRIEF

published on 05/08/2024 at 20:45, 1 year 6 months ago

EnVVeno Medical Reports Promising First Quarter 2024 Results and Upcoming FDA Filings

Medical Devices Clinical Data EnVVeno Medical Q1 2024 Financial Results VenoValve FDA Approval
PRESS RELEASE

published on 05/08/2024 at 20:40, 1 year 6 months ago

enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reported ending the quarter with $42.9 million cash and investments to fund operations through 2025, presenting positive data at the 46th Annual Charing Cross Symposium

Financial Results EnVVeno Medical Corporation SAVVE Trial Venous Disease VenoValve FDA Approval

Accesswire

Published on 12/05/2025 at 02:35, 9 hours 7 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 9 hours 12 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 10 hours 42 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 37 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 42 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 11:14, 28 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 1 hour 12 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 27 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 2 hours 2 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 2 hours 12 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany

Les Echos

Published on 12/05/2025 at 08:45, 2 hours 57 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 17 hours 42 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 17 hours 57 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 17 hours 58 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 4 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE